KYSE-30 ESCC cells harboring epidermal growth factor receptor (EGFR) overexpression and TP53 mutations [25,26,27] can generate tumors in xenografts of orthotopic and subcutaneous implantation [28,29]. Here, EGFR is linked to esophageal squamous cell carcinoma.